Finance

Lists
2VF0:FRA
Hemostemix Inc
€0.030
+7.14%
(+0.0020) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2VF0...
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
15.86M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.05
52-wk low
€0.02
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
15.86M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.05
52-wk low
€0.02
About Hemostemix Inc
CEO-
Employees-
Founded-
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
401.55K
2.08M
272.64K
9.32K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
879.88K
120.19K
353.65K
493.73K
Operating expense
1.76M
2.30M
645.85K
505.08K
Total operating expenses
1.76M
2.30M
645.85K
505.08K
Operating income
-1.76M
-2.30M
-645.85K
-505.08K
Other non operating income
315.78K
-789.35K
-195.81K
-100.66K
EBT including unusual items
-497.76K
-2.62M
-789.98K
-632.42K
EBT excluding unusual items
-1.48M
-3.15M
-926.72K
-654.50K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-497.76K
-2.62M
-789.98K
-632.42K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
79.47K
-
-
Interest expense
-193.39K
-
-59.88K
-61.25K
Net interest expenses
-193.39K
79.47K
-59.88K
-61.25K
Depreciation and amortization charges
11.00
12.00
5.00
5.00
EBITDA
-1.76M
-2.30M
-645.84K
-505.08K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps